Deutsche Bank Aktiengesellschaft Lowers Grifols (NASDAQ:GRFS

Grifols (NASDAQ:GRFS – Get Free Report) was downgraded by investment analysts at Deutsche Bank Aktiengesellschaft from a “hold” rating to a “sell” rating in a report issued on Tuesday, Marketbeat Ratings reports. Separately, JPMorgan Chase & Co. increased their target price on Grifols from $10.00 to $10.50 and gave the company a “neutral” rating in […]

Related Keywords

Spain , Canada , United States , America , Vistaseal Veraseal , Albutein Flexbag , Deutsche Bank Aktiengesellschaft , Jpmorgan Chase Co , America Corp , First Trust Advisors , Nasdaq , Creek Investment Management Inc , Get Free Report , Marketbeat Ratings , Trading Down , World Investors , Investment Partners , Creek Investment Management , Trust Advisors , Gamunexc Immune Globulin Injection , Flebogamma Immune Globulin Intravenous , Xembify Immune Globulin Subcutaneous , Immune Globulin , Lynspad Alpha , Proteinase Inhibitor , Human Albumin , Plasbumin Albumin , Grifols Daily ,